Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII.
about
Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of N-substituted benzenesulfonamides to human isoform IIThe structural comparison between membrane-associated human carbonic anhydrases provides insights into drug design of selective inhibitorsA Combined Crystallographic and Theoretical Study Explains the Capability of Carboxylic Acids to Adopt Multiple Binding Modes in the Active Site of Carbonic AnhydrasesSystematic enrichment analysis of gene expression profiling studies identifies consensus pathways implicated in colorectal cancer development.The synthesis of biologically relevant conjugates of Re(CO)3 using pyridine-2-carboxyaldehydeNear-Infrared Fluorescence Imaging of Carbonic Anhydrase IX in Athymic Mice Bearing HT-29 Tumor XenograftsSulfonamides: a patent review (2008 - 2012).Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013).Histopathological determinants of tumor resistance: a special look to the immunohistochemical expression of carbonic anhydrase IX in human cancers.Insights into the role of reactive sulfhydryl groups of Carbonic Anhydrase III and VII during oxidative damage.Carbonic Anhydrase Inhibition and the Management of Hypoxic Tumors.Sulfa drugs as inhibitors of carbonic anhydrase: new targets for the old drugs.Propargyl vinyl ethers as heteroatom-tethered enyne surrogates: diversity-oriented strategies for heterocycle synthesis.Structural modulation of the biological activity of gold nanoparticles functionalized with a carbonic anhydrase inhibitor.Synthesis, biological activity and multiscale molecular modeling studies for coumaryl-carboxamide derivatives as selective carbonic anhydrase IX inhibitors.Synthesis and biological evaluation of benzenesulphonamide-bearing 1,4,5-trisubstituted-1,2,3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory activity.Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy.Dipotassium-trioxohydroxytetrafluorotriborate, K₂[B₃O₃F₄OH], is a potent inhibitor of human carbonic anhydrases.Crystal structure of the human carbonic anhydrase II adduct with 1-(4-sulfamoylphenyl-ethyl)-2,4,6-triphenylpyridinium perchlorate, a membrane-impermeant, isoform selective inhibitor.Chemometric modeling of breast cancer associated carbonic anhydrase IX inhibitors belonging to the ureido-substituted benzene sulfonamide class.Tuning the Dual Inhibition of Carbonic Anhydrase and Cyclooxygenase by Dihydrothiazole Benzensulfonamides
P2860
Q27674538-3D19389C-77A2-49D2-9D4B-E4885616F8C1Q27688043-F632E7B4-5840-4AEF-AC9D-1786E0536B98Q27702530-960C6B16-478D-4333-BBFC-7313D2D06205Q34772247-F596BB3E-96F2-4E60-A260-CFFE4E971FB5Q37105624-9668D057-D306-41C9-B1B4-6515B7E16279Q37250091-5257409D-310C-40D8-BE58-1F02722C9E30Q38018632-5B12F72F-9713-4866-B3A6-3C4151CA5142Q38106734-0B6FDD49-782B-4E79-B15E-408B811DB5F7Q38132855-F44AAE85-BD25-4232-B8CC-87C14F5A6BB5Q38987207-4B8B7D88-45E8-43A3-8A9C-95EF9FC91676Q41666673-D5BD369A-0126-481D-A84A-9B59DFDAC61FQ42061370-D2E1E812-76F5-4745-9429-B889FFB668D3Q44072148-FE9198B8-6DAD-44C1-93FE-364955924A83Q45804276-06966ACF-6DB6-40B4-A460-296A0C3E71D9Q47738911-9A8E377B-2115-4D17-8835-529D4E9A5255Q47824587-2B4D842C-4217-40FA-9353-5B42B6E43C11Q48552373-A43A1393-6A8E-4E6A-96CC-6DC113D7EBFEQ48710407-734040ED-59BB-4385-B702-BC07393B17A2Q49332625-037403DD-595B-47EA-9BC4-711AA4EBADE3Q51112888-FA612569-124B-4CB9-B842-2E3E50DE4A9CQ57822075-9B44BE16-431B-457B-B938-4BA2F94F3CAC
P2860
Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII.
@en
Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII.
@nl
type
label
Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII.
@en
Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII.
@nl
prefLabel
Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII.
@en
Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII.
@nl
P1476
Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII.
@en
P2093
C T Supuran
O Ozensoy Guler
P304
P356
10.2174/092986710790979999
P577
2010-01-01T00:00:00Z